GlassScriptPhysician profile
Larissa Figari
NPI 1891993689
$1,618.35
in general payments reported to CMS, 2019-2025
11 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $124 · 2021: $308 · 2022: $564 · 2023: $321 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $652.31 | 2019-2025 | Invisalign, Itero Element 5d Plus, Invisalign First - Comprehensive |
| Straumann USA LLC | $365.01 | 2022 | |
| Thommen Medical USA, LLC | $166.67 | 2021 | |
| Dentsply Sirona INC | $133.17 | 2019-2023 | Waveone Gold Conform Fit, Smartlite Focus |
| Patterson Companies, INC. | $115.42 | 2025 | |
| Zimmer Biomet Holdings, INC. | $49.04 | 2019-2020 | |
| Envista Holdings Corporation | $40.27 | 2025 | Optibond Solo Plus |
| Zimvie INC. | $37.59 | 2023 | |
| Tulsa Dental Products LLC | $26.74 | 2019 | |
| Biohorizons Implant Systems INC. | $19.82 | 2020 | |
| Geistlich Pharma, North America, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larissa Figari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.